UroGen Pharma URGN Total Current Liabilities
Total Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by UroGen Pharma in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.
The official record: UroGen Pharma’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about UroGen Pharma's total current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is UroGen Pharma's total current liabilities?
- UroGen Pharma (URGN) reported total current liabilities of $50.64M in Q1 2026.
- How has UroGen Pharma's total current liabilities changed year-over-year?
- UroGen Pharma's total current liabilities increased by 20.6% year-over-year, from $42M to $50.64M.
- What is the long-term trend for UroGen Pharma's total current liabilities?
- Over 5 years (2020 to 2025), UroGen Pharma's total current liabilities has grown at a 16.7% compound annual growth rate (CAGR), from $21.44M to $46.42M.
- What does total current liabilities mean?
- The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.